Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

1.4K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

586
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
586
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

686
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
686
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

557
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
557
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

535
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

460
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
460

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pushing the Age Limit: Mitral Valve Surgery Is Safe and Effective in Octogenarians.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Impact and outcomes of failure mode after mitral valve repair.

The Journal of thoracic and cardiovascular surgery·2026
Same author

A Reverse Saddle Mitral Annulus Shape Explains Apparent Systolic Mitral Annular Disjunction in Mitral Valve Prolapse: A Three-Dimensional Transesophageal Echocardiography Analysis.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography·2026
Same author

The 2026 American Association for Thoracic Surgery Expert Consensus Document: Management of atrial functional mitral regurgitation.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Long-Term Survival Advantage of Reoperative Surgical Mitral Valve Replacement Over Transcatheter Mitral Valve-in-Valve: A Multicenter Cohort.

The Annals of thoracic surgery·2026
Same author

Durability of Mitral Valve Repair in Adult Connective Tissue Disease.

The Annals of thoracic surgery·2026

Related Experiment Video

Updated: May 5, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

10.9K

Mitral valve surgery: wait and see vs. early operation.

Michele De Bonis1, Steven F Bolling

  • 1Department of Cardiac Surgery, San Raffaele University Hospital, Milan 20132, Italy. michele.debonis@hsr.it

European Heart Journal
|August 31, 2012
PubMed
Summary

For severe mitral regurgitation, early mitral valve repair is debated in asymptomatic patients without LV dysfunction. This review discusses watchful waiting versus early surgery based on observational studies.

More Related Videos

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

3.7K
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.9K

Related Experiment Videos

Last Updated: May 5, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

10.9K
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

3.7K
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.9K

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery
  • Heart Valve Repair

Background:

  • Severe degenerative mitral regurgitation often requires surgical intervention.
  • Current guidelines recommend mitral valve repair for symptomatic patients or those with left ventricular (LV) dysfunction.
  • In asymptomatic patients with preserved LV function, indications for surgery include atrial fibrillation (AF) or pulmonary hypertension.

Purpose of the Study:

  • To review the current debate on the optimal timing of mitral valve repair in asymptomatic patients with preserved LV function, normal pulmonary artery pressure, and no AF.
  • To discuss the advantages, drawbacks, and requirements of both a 'wait and see' approach and an 'early repair' policy.
  • To analyze findings from significant observational studies in the absence of randomized trial data.

Main Methods:

  • Review of observational studies focusing on the timing of mitral valve repair for degenerative mitral regurgitation.
  • Discussion of clinical outcomes and patient selection criteria for different surgical timing strategies.
  • Synthesis of evidence to inform decision-making in cases lacking clear guideline indications.

Main Results:

  • No randomized trials directly compare watchful waiting versus early repair in asymptomatic patients with preserved LV function and normal pulmonary artery pressure.
  • Observational studies provide insights into the potential benefits and risks of each approach.
  • The optimal strategy remains controversial, highlighting the need for careful patient evaluation.

Conclusions:

  • The decision for mitral valve repair timing in select asymptomatic patients requires careful consideration of individual risk factors and potential outcomes.
  • Further research, ideally randomized controlled trials, is needed to definitively establish the best surgical timing strategy.
  • Current evidence from observational studies suggests a nuanced approach based on patient-specific factors is necessary.